Profiles

Keywords
Last Name
Institution

Gary Chmielewski

Concepts (238)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
20
2020
753
1.870
Why?
Carcinoma, Non-Small-Cell Lung
11
2017
367
1.110
Why?
Thoracotomy
4
2016
34
0.930
Why?
Pneumonectomy
5
2020
89
0.830
Why?
Esophageal Neoplasms
3
2015
61
0.720
Why?
Thoracic Surgery, Video-Assisted
3
2020
22
0.680
Why?
Unnecessary Procedures
2
2019
30
0.630
Why?
Adenocarcinoma
7
2015
235
0.630
Why?
Esophagectomy
2
2011
25
0.570
Why?
Barrett Esophagus
4
2015
19
0.570
Why?
Catheter Ablation
4
2015
78
0.530
Why?
Esophageal Diseases
1
2011
7
0.460
Why?
Jejunostomy
1
2011
8
0.460
Why?
Enteral Nutrition
1
2011
64
0.440
Why?
Abnormalities, Drug-Induced
4
2016
9
0.430
Why?
Aged
26
2019
10156
0.420
Why?
Neoplasm Recurrence, Local
3
2017
230
0.410
Why?
Empyema, Pleural
1
2009
1
0.400
Why?
Negative-Pressure Wound Therapy
1
2009
5
0.390
Why?
Neoplasm Staging
12
2019
516
0.380
Why?
Intraoperative Complications
1
2009
75
0.380
Why?
Echinocandins
3
2012
7
0.360
Why?
Positron-Emission Tomography
3
2011
92
0.360
Why?
Surgical Wound Infection
1
2009
102
0.350
Why?
Male
29
2019
17552
0.350
Why?
Drainage
2
2009
55
0.350
Why?
Toxicity Tests
4
2016
9
0.340
Why?
Female
30
2019
18107
0.340
Why?
Postoperative Complications
4
2016
1084
0.320
Why?
Embryonic Development
3
2016
8
0.320
Why?
Retrospective Studies
11
2017
3456
0.300
Why?
Embryo, Mammalian
2
2016
37
0.290
Why?
Humans
32
2020
30741
0.280
Why?
Solitary Pulmonary Nodule
2
2015
14
0.280
Why?
Carcinoma, Squamous Cell
2
2019
198
0.270
Why?
Middle Aged
20
2017
11256
0.270
Why?
Bronchoscopy
3
2019
38
0.260
Why?
Pleurodesis
1
2003
2
0.260
Why?
Pleural Effusion, Malignant
1
2003
6
0.260
Why?
Consensus
2
2020
96
0.250
Why?
Prognosis
6
2017
1045
0.240
Why?
Radiosurgery
3
2011
40
0.230
Why?
Antifungal Agents
2
2012
42
0.230
Why?
Aged, 80 and over
12
2017
5172
0.230
Why?
Treatment Outcome
11
2017
3850
0.220
Why?
Survival Analysis
5
2017
398
0.220
Why?
Education, Medical, Graduate
1
2020
82
0.200
Why?
Surgeons
1
2020
76
0.200
Why?
Small Cell Lung Carcinoma
1
2019
13
0.200
Why?
False Positive Reactions
1
2019
40
0.200
Why?
Computer Simulation
1
2020
246
0.200
Why?
Fetal Development
2
2016
6
0.190
Why?
Cohort Studies
4
2017
1959
0.190
Why?
Fetus
2
2016
62
0.190
Why?
Registries
4
2015
203
0.180
Why?
Bone and Bones
2
2016
111
0.180
Why?
Neovascularization, Pathologic
2
2015
70
0.180
Why?
Tracheomalacia
1
2017
5
0.170
Why?
Tracheal Stenosis
1
2017
8
0.170
Why?
Silicones
1
2017
14
0.170
Why?
Airway Obstruction
1
2017
22
0.170
Why?
Length of Stay
3
2016
371
0.170
Why?
Mutagenicity Tests
1
2016
1
0.170
Why?
Hazardous Substances
1
2016
2
0.170
Why?
Multivariate Analysis
5
2017
391
0.170
Why?
Teratogens
1
2016
2
0.170
Why?
Clinical Competence
2
2020
268
0.170
Why?
Insulin-Like Growth Factor I
2
2014
60
0.160
Why?
Pharmaceutical Preparations
1
2016
22
0.160
Why?
Risk Assessment
4
2017
804
0.160
Why?
Developmental Biology
1
2016
1
0.160
Why?
Thoracic Wall
1
2016
11
0.160
Why?
Models, Animal
1
2016
150
0.160
Why?
Ribs
1
2016
19
0.160
Why?
Metformin
1
2016
21
0.160
Why?
Sensitivity and Specificity
2
2009
594
0.160
Why?
X-Ray Microtomography
1
2016
70
0.150
Why?
Stents
1
2017
158
0.150
Why?
Disease Progression
4
2014
851
0.150
Why?
Esophagoscopy
1
2015
18
0.150
Why?
Learning Curve
1
2015
19
0.150
Why?
Hypoglycemic Agents
1
2016
76
0.150
Why?
Thoracoscopy
2
2019
19
0.150
Why?
Insulin-Like Growth Factor II
1
2014
10
0.140
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
15
0.140
Why?
Rats
5
2016
954
0.140
Why?
Cytokines
2
2014
348
0.140
Why?
Tumor Burden
3
2010
44
0.140
Why?
Intubation, Intratracheal
2
2016
66
0.130
Why?
Animals
8
2016
5221
0.130
Why?
Kaplan-Meier Estimate
2
2015
230
0.130
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
13
0.130
Why?
Multiple Pulmonary Nodules
1
2013
9
0.130
Why?
Diabetes Mellitus, Type 2
1
2016
222
0.130
Why?
Prosthesis Failure
1
2017
526
0.130
Why?
Fundoplication
1
2012
24
0.120
Why?
Research Design
2
2012
230
0.120
Why?
Gastroesophageal Reflux
1
2012
33
0.120
Why?
Immunoassay
1
2012
44
0.120
Why?
Nitriles
1
2012
17
0.120
Why?
Pyrimidines
1
2012
32
0.120
Why?
Diagnosis, Differential
2
2015
469
0.120
Why?
Predictive Value of Tests
4
2016
631
0.120
Why?
Triazoles
1
2012
35
0.120
Why?
Gastric Fistula
1
2011
4
0.120
Why?
Fistula
1
2011
7
0.120
Why?
Disease-Free Survival
3
2017
247
0.120
Why?
Dose-Response Relationship, Drug
4
2016
527
0.110
Why?
Nutrition Assessment
1
2011
53
0.110
Why?
Hospitals, Community
1
2011
22
0.110
Why?
Community-Institutional Relations
1
2011
15
0.110
Why?
Pyrazoles
1
2012
55
0.110
Why?
Radiography, Interventional
1
2011
30
0.110
Why?
Medical Oncology
1
2011
39
0.110
Why?
Anticarcinogenic Agents
1
2010
21
0.110
Why?
Tomography, X-Ray Computed
5
2015
876
0.110
Why?
Receptor, IGF Type 1
1
2010
21
0.110
Why?
Minority Groups
1
2011
71
0.110
Why?
Behavior, Animal
1
2011
109
0.110
Why?
Bronchi
1
2010
19
0.110
Why?
Prospective Studies
5
2015
1891
0.110
Why?
Algorithms
3
2014
421
0.110
Why?
Adult
8
2017
9760
0.110
Why?
Trachea
1
2010
23
0.100
Why?
Heart Diseases
1
2011
102
0.100
Why?
Thoracic Surgical Procedures
1
2009
12
0.100
Why?
Risk Factors
5
2015
2611
0.100
Why?
Probability
1
2009
107
0.100
Why?
Age Factors
2
2009
941
0.100
Why?
Patient Selection
1
2011
259
0.100
Why?
Thoracic Surgery
1
2009
33
0.100
Why?
Statistics, Nonparametric
1
2009
162
0.100
Why?
Area Under Curve
3
2014
78
0.100
Why?
Clinical Trials as Topic
1
2011
386
0.100
Why?
Antibodies, Monoclonal
1
2010
311
0.090
Why?
Staphylococcus aureus
1
2009
83
0.090
Why?
Body Mass Index
1
2011
438
0.090
Why?
Survival Rate
2
2010
478
0.090
Why?
Recurrence
2
2014
390
0.090
Why?
Neoplasms
1
2011
275
0.090
Why?
Rats, Inbred F344
3
2012
51
0.090
Why?
Laparoscopy
1
2009
188
0.090
Why?
United States
4
2015
2467
0.080
Why?
Staphylococcal Infections
1
2009
172
0.080
Why?
Neoplasm Invasiveness
2
2017
109
0.080
Why?
Lung
2
2005
169
0.080
Why?
Rabbits
2
2016
327
0.080
Why?
Pregnancy
3
2012
452
0.080
Why?
Pneumonia
2
2019
75
0.080
Why?
Protein-Lysine 6-Oxidase
1
2005
1
0.080
Why?
Carcinoma, Bronchogenic
1
2005
14
0.070
Why?
Minimally Invasive Surgical Procedures
1
2009
296
0.070
Why?
Time Factors
3
2015
1911
0.070
Why?
Logistic Models
2
2015
479
0.070
Why?
ROC Curve
2
2014
155
0.070
Why?
Catheters, Indwelling
1
2003
29
0.060
Why?
Follow-Up Studies
3
2014
2046
0.060
Why?
Proton Pump Inhibitors
2
2012
15
0.060
Why?
Reproducibility of Results
2
2016
875
0.060
Why?
Incidence
2
2015
827
0.060
Why?
Brain
1
2011
1574
0.060
Why?
Mediastinoscopy
1
2019
5
0.050
Why?
Sex Factors
2
2012
535
0.050
Why?
Reoperation
2
2015
918
0.050
Why?
Early Detection of Cancer
1
2019
91
0.040
Why?
Radiography
2
2013
714
0.040
Why?
Dilatation
1
2017
13
0.040
Why?
Pulmonary Diffusing Capacity
1
2016
10
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
36
0.040
Why?
Pneumonia, Bacterial
1
2016
15
0.040
Why?
Young Adult
2
2014
2249
0.040
Why?
Tracheostomy
1
2016
27
0.040
Why?
Protective Factors
1
2015
18
0.040
Why?
Observer Variation
1
2016
146
0.040
Why?
Chemoradiotherapy, Adjuvant
1
2015
21
0.040
Why?
Least-Squares Analysis
1
2015
9
0.040
Why?
Hospitals, Low-Volume
1
2015
7
0.040
Why?
Hospitals, High-Volume
1
2015
10
0.040
Why?
Guidelines as Topic
1
2016
78
0.040
Why?
Cause of Death
1
2015
74
0.040
Why?
Databases, Factual
1
2017
372
0.040
Why?
Remission Induction
1
2015
127
0.040
Why?
Chi-Square Distribution
1
2015
181
0.040
Why?
Minnesota
1
2014
12
0.040
Why?
Proportional Hazards Models
1
2016
385
0.040
Why?
Diabetes Mellitus
1
2016
140
0.040
Why?
Linear Models
1
2015
277
0.040
Why?
Odds Ratio
1
2015
328
0.030
Why?
Illinois
1
2014
268
0.030
Why?
Chemokine CCL3
1
2013
12
0.030
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
15
0.030
Why?
Granuloma
1
2013
16
0.030
Why?
Chemokine CXCL12
1
2013
9
0.030
Why?
Interleukin-10
1
2013
42
0.030
Why?
Respiratory Tract Infections
1
2013
53
0.030
Why?
Maternal Exposure
1
2012
2
0.030
Why?
Interleukin-6
1
2013
120
0.030
Why?
Decision Support Techniques
1
2012
54
0.030
Why?
Voriconazole
1
2012
7
0.030
Why?
Injections, Subcutaneous
1
2012
45
0.030
Why?
Lymphatic Metastasis
1
2012
111
0.030
Why?
Tissue Distribution
1
2012
50
0.030
Why?
Drug Evaluation, Preclinical
1
2012
39
0.030
Why?
Animals, Newborn
1
2012
77
0.030
Why?
Cesarean Section
1
2012
33
0.030
Why?
Drug Combinations
1
2012
88
0.030
Why?
Hematemesis
1
2011
2
0.030
Why?
Stomach Ulcer
1
2011
5
0.030
Why?
Tumor Necrosis Factor-alpha
1
2013
228
0.030
Why?
Esophageal Perforation
1
2011
10
0.030
Why?
Administration, Oral
1
2012
165
0.030
Why?
Candidiasis
1
2011
18
0.030
Why?
Osteogenesis
1
2012
94
0.030
Why?
Fatal Outcome
1
2011
76
0.030
Why?
Body Weight
1
2012
165
0.030
Why?
Gastrointestinal Hemorrhage
1
2011
29
0.030
Why?
Michigan
1
2011
20
0.030
Why?
Sex Distribution
1
2011
91
0.030
Why?
Feeding Behavior
1
2012
123
0.030
Why?
Radiopharmaceuticals
1
2011
64
0.030
Why?
Organogenesis
1
2010
2
0.030
Why?
Maternal-Fetal Exchange
1
2010
11
0.030
Why?
Macaca fascicularis
1
2010
28
0.030
Why?
Immunoglobulins, Intravenous
1
2010
22
0.030
Why?
Program Evaluation
1
2011
152
0.030
Why?
Contrast Media
1
2011
147
0.030
Why?
Healthcare Disparities
1
2011
79
0.030
Why?
Rupture
1
2010
115
0.030
Why?
Hospitalization
1
2012
344
0.020
Why?
Comorbidity
1
2011
562
0.020
Why?
Motor Activity
1
2011
395
0.020
Why?
Radiotherapy Dosage
1
2007
147
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2007
74
0.020
Why?
Mice
1
2012
1843
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
206
0.020
Why?
RNA, Messenger
1
2005
361
0.020
Why?
Cognition
1
2011
1141
0.020
Why?
Aging
1
2012
1551
0.010
Why?
Chmielewski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description